Prenatal cocaine increases striatal serotonin innervation without altering the patch/matrix organization of intrinsic cell types.
The effect of prenatal cocaine on the anatomical development of the striatum was examined. The distribution and density of dopaminergic innervation of the striatum of animals exposed to cocaine during the second and third week of gestation was not noticeably different from prenatally saline-injected or untreated controls at any age. The patch/matrix organization of the striatum also appeared unaltered: neurons exhibiting dense substance P staining were localized to patches that overlapped dopamine terminal patches early in development, and enkephalin- and calbindin-immunoreactive neurons were found segregated to the matrix. Histochemical staining for acetylcholinesterase and NADPH diaphorase also revealed no differences between prenatally cocaine-treated and control brains. Whereas prenatal cocaine treatment failed to modify the basic compartmental organization of the striatum, it did lead to a hyperinnervation of serotonin-immunoreactive fibers which developed slowly after birth. Thus prenatal exposure to cocaine is capable of altering the ingrowth of serotonergic projections to the striatum while producing no change in the organization of neurons intrinsic to the striatum.
Snyder-Keller
A M
AM
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201.
Keller
R W
RW
D000110:Acetylcholinesterase / Q000276:immunology / Q000378:metabolism; D000375:Aging / Q000502:physiology; D000818:Animals; D064026:Calbindins; D003042:Cocaine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D004745:Enkephalins / Q000276:immunology / Q000378:metabolism; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D009252:NADPH Dehydrogenase / Q000276:immunology / Q000378:metabolism; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D064030:S100 Calcium Binding Protein G / Q000276:immunology / Q000378:metabolism; D012701:Serotonin / Q000502:physiology*; D013373:Substance P / Q000276:immunology / Q000378:metabolism; D013378:Substantia Nigra / Q000166:cytology / Q000187:drug effects
D064026:Calbindins; D004745:Enkephalins; D064030:S100 Calcium Binding Protein G; D012701:Serotonin; D013373:Substance P; D009252:NADPH Dehydrogenase; D000110:Acetylcholinesterase; D003042:Cocaine